- Sami Hamadé
- Darren Hite
- Vince Kim
- Paul Klingenstein
- Naheed Misfeldt
- Jake Odden
- Sigrid Van Bladel
- • Admin Team •
Christina Fong
Jackie Kortz
Judy Stralka
Maureen Valentini
Paul Klingenstein, Managing Partner
- Founded Aberdare in 1999 after 16 years of healthcare investing
- Began healthcare-focused venture career at Warburg Pincus in early 1980s
- Joined Accel in 1986; built and led top tier healthcare practice
- 1998 at Rockefeller Foundation building private-public partnerships
- Current board chair: International Aids Vaccine Initiative
- Former not-for-profit and chair roles at various school, conservation and community development organizations
- Stanford MBA; AB, Harvard
Current Aberdare Boards:
Anacor (ANAC), Aviir, EnteroMedics (ETRM), Conatus, Clovis Oncology, VertiFlex
Select Former Boards / Investments:
Ironwood (IRWD), Pharmion, Idun Pharmaceuticals, Salmedix, Aviron, EP Technologies, Isis Pharmaceuticals, Viagene US Behavioral Health, Xomed Surgical Products
 |
"Paul is the most constructive pain in the ass I have ever worked with or had on my board." - Leighton Read, Former CEO, Aviron |
 |
|
"Paul is no-nonsense. Real insights. Cut-to-the-chase. Let's not panic. He is smart, and extremely effective in drawing focus to the key issues at hand. He doesn't spend time on all the noise." - Doug Harrington, CEO, Aviir |
|
|
"Paul values his time and quality of life. There is a "no assholes rule." Paul doesn't want to invest in or work with people who break the rule. Consequently, dealing with him and others at the firm is a pleasure. Paul really is an exception." – David Perry, CEO, Anacor Pharmaceuticals | |
|
"In the difficult times, Paul offers a non-anxious presence, keeping things constructive and solution oriented. This capacity for leadership is an extraordinary gift to an organization, and CEO and an entrepreneur." – Mark Knudson, CEO, EnteroMedics | |